Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning
Olle Ringdén(Karolinska Institutet), Navneet S. Majhail, Mohamed L. Sorror(University of Washington Medical Center), Gèrard Socié(Hôpital Saint-Louis), Robert J. Hayashi(Washington University in St. Louis), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Naynesh Kamani(American Association of Blood Banks), Ibrahim Ahmed(Children's Mercy Hospital), Harry C. Schouten, Alison W. Loren(University of Pennsylvania), Hillard M. Lazarus(University Hospitals Cleveland Medical Center), Yoshiko Atsuta(Aichi Medical University), David Buchbinder(Children's Hospital of Orange County), Nandita Khera(Mayo Clinic in Florida), Wael Saber(Medical College of Wisconsin), Uday Popat(The University of Texas MD Anderson Cancer Center), Ruta Brazauskas(Medical College of Wisconsin), David A. Jacobsohn(Center for Cancer and Blood Disorders), Jonas Mattsson(University Health Network), Amir Steinberg(Mount Sinai Medical Center), Linda J. Burns(University of Minnesota System), Bipin N. Savani(Vanderbilt University Medical Center), Muthalagu Ramanathan(UMass Memorial Health Care), Zhiwei Wang(Beth Israel Deaconess Medical Center), Rammurti T. Kamble(Baylor College of Medicine), Jean‐Yves Cahn(Université Grenoble Alpes), Christine Duncan(Dana-Farber Cancer Institute), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Joerg Halter(University Hospital of Basel), Gregory A. Hale(Johns Hopkins University), John R. Wingard(Radboud University Nijmegen), Jack W. Hsu(University of Florida Health), Kasiani C. Myers(Cincinnati Children's Hospital Medical Center)
Cited by 67
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k